Lumexa Imaging Appoints Kyle Lynch to Drive 185-Center Network Expansion
Lynch will lead Lumexa Imaging’s growth strategy, overseeing joint ventures, acquisitions and de novo center development to drive profitable expansion. Lumexa operates over 185 outpatient imaging centers in 13 states and conducted roughly 4 million procedures in 2025 as it positions for site-of-care migration and advanced diagnostics demand.
1. Chief Growth Officer Appointment
On April 20, 2026 Lumexa Imaging appointed Kyle Lynch as Chief Growth Officer, adding him to the executive leadership team to spearhead enterprise expansion efforts.
2. Growth Strategy and Responsibilities
Lynch will oversee the full growth lifecycle—opportunity origination, transaction execution and post-close value realization—with a mandate to expand the platform through joint ventures, acquisitions and new center development aimed at maximizing return on invested capital.
3. Platform Scale and Market Opportunity
Lumexa Imaging operates more than 185 outpatient centers across 13 states and performed approximately 4 million procedures system-wide in 2025, positioning the company to capitalize on site-of-care migration and rising demand for advanced diagnostics.